FDA narrows drug label usage.
Dolgin
Elie
E
D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D011905:Genes, ras / Q000235:genetics; D005819:Genetic Markers / Q000235:genetics; D005820:Genetic Testing; D006801:Humans; D000077544:Panitumumab; D010597:Pharmacogenetics; D016032:Randomized Controlled Trials as Topic; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005819:Genetic Markers; D000077544:Panitumumab; D000068818:Cetuximab